Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mastocytosis.

M D Tharp1, B J Longley

  • 1Department of Dermatology, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois, USA.

Dermatologic Clinics
|November 14, 2001
PubMed
Summary
This summary is machine-generated.

Mastocytosis is a group of disorders caused by mast cell infiltration. Recent discoveries explain its development, leading to better management strategies for patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of lesional skin c-KIT mutations with clinical phenotype in patients with mastocytosis.

Clinical and experimental dermatology·2018
Same author

Primary cutaneous adenosquamous carcinoma of the penis: the first characterization of HPV status in this rare and diagnostically challenging entity with review of glandular carcinomas of the penis.

Journal of cutaneous pathology·2016
Same author

Distinct signalling pathways for mutated KIT(V560G) and KIT(D816V) in mastocytosis.

Clinical and experimental dermatology·2013
Same author

Mutations in the PSTPIP1 gene and aberrant splicing variants in patients with pyoderma gangrenosum.

Clinical and experimental dermatology·2011
Same author

Recurrent missense mutations in the hair keratin gene hHb6 in monilethrix.

Clinical and experimental dermatology·2003
Same author

Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy.

Leukemia research·2001
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Hematology
  • Immunology
  • Dermatology

Background:

  • Mastocytosis is a rare disorder characterized by mast cell accumulation in various tissues.
  • Despite being known for over a century, the underlying pathophysiology remains incompletely understood.
  • Recent advancements have shed light on the molecular mechanisms driving mast cell proliferation.

Purpose of the Study:

  • To review the clinical manifestations of mastocytosis.
  • To elucidate the recently identified pathophysiologic mechanisms of mastocytosis.
  • To outline effective treatment strategies for mastocytosis.

Main Methods:

  • Literature review of clinical studies and recent research.
  • Analysis of pathophysiologic pathways involved in mast cell disorders.

Related Experiment Videos

  • Synthesis of current therapeutic approaches.

    • Main Results:

    • Mastocytosis presents with diverse clinical features depending on organ involvement.
    • Specific genetic mutations and signaling pathways are implicated in mast cell dysregulation.
    • Targeted therapies show promise in managing mastocytosis symptoms.

    Conclusions:

    • Understanding the pathophysiology of mastocytosis is crucial for effective treatment.
    • Personalized treatment approaches based on disease mechanisms are emerging.
    • Continued research is vital for improving patient outcomes in mastocytosis.